Canada Life’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.31M Buy
111,695
+893
+0.8% +$52.1K 0.01% 655
2025
Q4
$6.58M Sell
110,802
-56,230
-34% -$3.06M 0.01% 644
2025
Q3
$9.02M Buy
167,032
+3,771
+2% +$216K 0.01% 589
2025
Q2
$8.97M Buy
163,261
+7,315
+5% +$431K 0.01% 581
2025
Q1
$11M Sell
155,946
-15,072
-9% -$1.01M 0.02% 536
2024
Q4
$11.2M Sell
171,018
-42,326
-20% -$2.84M 0.02% 536
2024
Q3
$15M Buy
213,344
+13,587
+7% +$1.14M 0.03% 482
2024
Q2
$16.5M Buy
199,757
+105,963
+113% +$8.82M 0.03% 437
2024
Q1
$8.2M Sell
93,794
-3,072
-3% -$275K 0.02% 618
2023
Q4
$9.28M Sell
96,866
-7,831
-7% -$693K 0.02% 550
2023
Q3
$9.26M Sell
104,697
-4,534
-4% -$403K 0.02% 532
2023
Q2
$9.53M Sell
109,231
-1,048
-1% -$98.6K 0.02% 531
2023
Q1
$10.7M Sell
110,279
-2,179
-2% -$226K 0.03% 508
2022
Q4
$11.7M Buy
112,458
+5,656
+5% +$531K 0.03% 486
2022
Q3
$9.04M Sell
106,802
-33,145
-24% -$2.95M 0.03% 532
2022
Q2
$11.6M Sell
139,947
-12,763
-8% -$1.02M 0.03% 497
2022
Q1
$12.5M Sell
152,710
-4,508
-3% -$377K 0.03% 519
2021
Q4
$13.9M Buy
157,218
+20,734
+15% +$1.71M 0.03% 511
2021
Q3
$10.6M Buy
136,484
+1,048
+0.8% +$82.7K 0.02% 563
2021
Q2
$11.3M Sell
135,436
-4,947
-4% -$392K 0.03% 565
2021
Q1
$10.5M Buy
140,383
+11,997
+9% +$980K 0.03% 589
2020
Q4
$11.2M Buy
128,386
+3,879
+3% +$308K 0.02% 581
2020
Q3
$9.46M Buy
124,507
+844
+0.7% +$85.4K 0.02% 548
2020
Q2
$15.2M Buy
123,663
+6,000
+5% +$596K 0.03% 427
2020
Q1
$10M Buy
117,663
+3,023
+3% +$260K 0.03% 462
2019
Q4
$9.62M Buy
114,640
+714
+0.6% +$53.9K 0.02% 573
2019
Q3
$7.68M Buy
113,926
+6,501
+6% +$501K 0.02% 586
2019
Q2
$9.19M Sell
107,425
-878
-0.8% -$75.1K 0.02% 574
2019
Q1
$9.58M Buy
108,303
+23,489
+28% +$2.18M 0.03% 504
2018
Q4
$6.93M Hold
84,814
0.02% 556
2018
Q3
$8.23M Sell
84,814
-12,678
-13% -$1.27M 0.02% 557
2018
Q2
$9.19M Buy
97,492
+544
+0.6% +$47.6K 0.02% 550
2018
Q1
$7.87M Sell
96,948
-2,386
-2% -$205K 0.02% 597
2017
Q4
$8.84M Buy
99,334
+3,918
+4% +$341K 0.02% 575
2017
Q3
$8.86M Sell
95,416
-48,923
-34% -$4.32M 0.02% 557
2017
Q2
$13.1M Buy
144,339
+3,432
+2% +$312K 0.03% 433
2017
Q1
$12.4M Buy
140,907
+51,882
+58% +$4.62M 0.03% 439
2016
Q4
$7.4M Sell
89,025
-103,314
-54% -$8.88M 0.02% 564
2016
Q3
$17.8M Buy
192,339
+34,547
+22% +$3.25M 0.05% 347
2016
Q2
$12.2M Buy
157,792
+75,583
+92% +$6.43M 0.04% 423
2016
Q1
$6.78M Buy
82,209
+2,124
+3% +$173K 0.02% 509
2015
Q4
$8.39M Buy
80,085
+3,170
+4% +$331K 0.03% 431
2015
Q3
$8.11M Buy
76,915
+5,168
+7% +$690K 0.03% 432
2015
Q2
$9.79M Buy
71,747
+114
+0.2% +$14.1K 0.03% 431
2015
Q1
$8.9M Buy
71,633
+16,153
+29% +$1.71M 0.03% 451
2014
Q4
$5.01M Sell
55,480
-11,800
-18% -$981K 0.02% 610
2014
Q3
$4.86M Buy
67,280
+3,563
+6% +$234K 0.02% 614
2014
Q2
$3.95M Buy
63,717
+2,029
+3% +$123K 0.01% 654
2014
Q1
$4.19M Buy
61,688
+31,646
+105% +$2.33M 0.01% 639
2013
Q4
$2.12M Buy
30,042
+3,567
+13% +$242K 0.01% 764
2013
Q3
$1.91M Buy
26,475
+15,175
+134% +$1.01M 0.01% 745
2013
Q2
$630K Buy
+11,300
New +$704K ﹤0.01% 513

Other funds holding BMRN